Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Saizen

- PMLiVE

UK biotech gains further £47.2m from Biomedical Catalyst funding

Programme aims to help bridge the 'valley of death' funding gap

- PMLiVE

Solid performance for Merck KGaA in “transformation year”

Sales and profits on track amid job cuts and restructuring

Interview: Steve Bates, BIA

The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces

- PMLiVE

Sir Tom Blundell to remain as chair of UK’s biotech research council

Reappointed to government role to support research

- PMLiVE

Late-stage failure for Merck’s cilengitide in brain cancer

Integrin inhibitor unable to improve overall survival in phase III trials

- PMLiVE

Online tycoons announce first winners of $33m research prize

Billionaire founders of Facebook and Google among those behind Breakthrough Prize in Life Sciences

- PMLiVE

Grünenthal’s Harald Stock joins OvaScience board

Provides European expertise as fertility company looks to expand beyond US

- PMLiVE

Merck KGaA and Opexa enter MS deal

Will develop personalised T-cell based medicine Tcelna

- PMLiVE

Merck KGaA starts third phase III trial for cancer hope TH-302

Unique method of action to target cells with low oxygen levels

Universities launch £50m fund for biopharma start-ups in UK

Will be managed by US group Rock Spring Ventures

Ischemix names David DeWahl as CEO

He joins the US biotech from private investment firm Colchester Healthcare Investments

- PMLiVE

Biotech challenging big pharma for M&A deals

Purchasing power growth of 'big biotech' outpaces pharma sector

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links